Condensed Consolidated Balance Sheets (unaudited) - USD ($) $ in Millions	Mar. 31, 2026	Dec. 31, 2025
Current Assets:
Cash and cash equivalents	$ 424.2	$ 591.9
Accounts receivable, less allowance for credit losses	1,728.6	1,704.4
Inventories	2,246.8	2,286.4
Prepaid expenses and other current assets	562.9	537.3
Total Current Assets	4,962.5	5,119.9
Property, plant and equipment, net	2,211.7	2,207.1
Goodwill	9,931.8	9,947.1
Intangible assets, net	4,547.6	4,717.3
Other assets	1,067.9	1,100.3
Total Assets	22,721.6	23,091.7
Current Liabilities:
Accounts payable	361.2	303.0
Salaries, wages and benefits	293.9	477.1
Other current liabilities	1,033.3	1,216.5
Current portion of long-term debt	1,175.9	587.1
Total Current Liabilities	2,864.3	2,583.7
Deferred income taxes, net	249.9	244.1
Other long-term liabilities	630.7	626.1
Long-term debt	6,295.1	6,932.0
Total Liabilities	10,040.0	10,386.0
Commitments and Contingencies (Note 16)
Stockholders' Equity:
Common stock, $0.01 par value, one billion shares authorized, 319.3 million shares as of March 31, 2026 (318.7 million as of December 31, 2025) issued	3.2	3.2
Paid-in capital	10,199.3	10,178.6
Retained earnings	11,802.5	11,611.0
Accumulated other comprehensive loss	(190.4)	(205.7)
Treasury stock, 125.9 million shares as of March 31, 2026 (123.2 million as of December 31, 2025)	(9,141.3)	(8,889.4)
Total Zimmer Biomet Holdings, Inc. stockholders' equity	12,673.3	12,697.7
Noncontrolling interest	8.2	8.1
Total Stockholders' Equity	12,681.6	12,705.8
Total Liabilities and Stockholders' Equity	$ 22,721.6	$ 23,091.7